Table 1 Participant characteristics

Full data set (2019-22)

Individuals - N (%)

173 (100)

67 (39)

106 (61)

Vaccination events - N (%)

423 (100)

166 (39)

257 (61)

Age at vaccination

 Mean (min-max)

85 (75–99)

85 (76–99)

84 (75–99)

 Median (IQR)

84 (81–88)

84 (82–88)

83 (81–88)

Gender subset (2020-22)

Individuals - N (%)

162 (100)

62 (38)

100 (62)

Vaccination events - N (%)

339 (100)

127 (37)

212 (63)

Age at vaccination

 Mean (min-max)

85 (75–99)

85 (76–99)

84 (75–99)

 Median (IQR)

84 (81–88)

84 (82–88)

83 (81–88)

Gender category - N (%)

 Masculine

65 (19)

37 (29)

28 (13)

 Feminine

70 (21)

21 (17)

49 (23)

 Androgynous

115 (34)

35 (28)

80 (38)

 Undifferentiated

89 (26)

34 (27)

55 (26)

Masculinity score

 Mean (min-max)

3.5 (1.3–5.0)

3.5 (1.5–5.0)

3.5 (1.3–5.0)

 Median (IQR)

3.5 (3.0–4.2)

3.5 (3.0–4.0)

3.5 (2.8–4.2)

Femininity score

 Mean (min-max)

4.1 (1.8–5.0)

4.0 (1.8–5.0)

4.2 (2.2–5.0)

 Median (IQR)

4.2 (3.7–4.7)

4.0 (3.5–4.5)

4.2 (3.8–4.7)

Serology subset (2020)

Vaccination events - N (%)

112 (100)

46 (41)

66 (59)

Age at vaccination

 Mean (min-max)

85 (75–98)

85 (76–98)

84 (75–98)

 Median (IQR)

83 (81–88)

84 (82–87)

83 (81–88)